Disclosed is an oxadiazole compound of formula (I) where R2 is an optionally substituted herteroaryl and R1 is an optionally substituted phenyl group. The optional substituents are as disclosed in the description. Also disclosed is a pharmaceutical composition comprising a compound of formula (I) and the use of a compound of formula (I) in the manufacture of a medicament for inhibiting DGATI. Further disclosed is the process for making a compound of formula (I).
申请公布号
NZ587106(A)
申请公布日期
2012.03.30
申请号
NZ20050587106
申请日期
2005.12.09
申请人
ASTRAZENECA AB
发明人
BIRCH, ALAN MARTIN;BOWKER, SUZANNE SAXON;BUTLIN, ROGER JOHN;DONALD, CRAIG SAMUEL;MCCOULL, WILLIAM;NOWAK, THORSTEN;PLOWRIGHT, ALLEYN